NASDAQ · Biotechnology

AXSM (AXSM) Stock

$209.92 +3.50% NASDAQ: AXSM Healthcare

Valuation

MetricValue
Price$209.92
Market Cap$10.80B
P/E Ratio-52.94
P/B Ratio122.73
P/S Ratio13.16
EPS (TTM)$-3.68
52-Week High$260.19
52-Week Low$112.90
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-255.60%
ROA-25.17%
ROCE-62.64%
Gross Margin92.60%
Operating Margin-24.80%
Net Margin-24.68%
Debt/Equity2.63
Current Ratio1.55

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$50.0M$271.0M$386.0M$638.0M
Operating Profit$-125.0M$-180.0M$-232.0M$-281.0M$-169.0M
Net Profit$-130.0M$-187.0M$-239.0M$-287.0M$-183.0M
EPS$-3.47$-4.60$-5.27$-5.99$-3.68
Op Margin—-359.3%-85.7%-72.7%-26.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$88.0M$331.0M$588.0M$568.0M$690.0M
Total Liabilities$72.0M$222.0M$397.0M$511.0M$602.0M
Cash$86.0M$201.0M$386.0M$315.0M$323.0M
Borrowings$50.0M$95.0M$186.0M$193.0M$241.0M

Latest News

Axsome Therapeutics Wins US FDA Review for Narcolepsy Drug Application MT Newswires · Jul 15, 2026 Axsome Therapeutics Announces FDA Acceptance of New Drug Application for AXS-12 for the Treatment of Cataplexy in Narcolepsy GlobeNewswire · Jul 15, 2026 Axsome Therapeutics to Report Second Quarter 2026 Financial Results on August 10 GlobeNewswire · Jul 14, 2026 3 Under-the-Radar Stocks to Buy and Hold Motley Fool · Jul 10, 2026 Axsome Therapeutics (AXSM) Stock Looks Pricey On Sales Yet Fair On Value Simply Wall St. · Jul 10, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-108.0M$-117.0M$-145.0M$-128.0M$-93.0M
Investing Cash Flow$-1.0M$-54.0M$-1.0M$-1.0M$-1.0M
Financing Cash Flow$4.0M$-4.0M$-13.0M$18.0M$-17.0M
Net Cash Flow$-97.0M$114.0M$185.0M$-71.0M$8.0M
Free Cash Flow$-109.0M$-117.0M$-146.0M$-129.0M$-94.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-1.86
EV / EBITDA-56.26
FCF Yield-0.70%
Quick Ratio1.34
Interest Coverage-37.58
Return 1Y63.47%
Return 3Y153.88%
Return 5Y763.12%

Ownership

Insiders Held15.35%
Institutions Held75.72%
Institutions Float Held89.45%
Institutional HolderSharesReport Date
Blackrock Inc.3,912,8442026-03-31
Vanguard Portfolio Management LLC2,058,1702026-03-31
Vanguard Capital Management LLC1,937,7522026-03-31
FMR, LLC1,566,9952026-03-31
Price (T.Rowe) Associates Inc1,317,0592026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ABVXAbivax S.A. $136.94 +1.50% -24.37 $10.06B 0.00%
ARWR $85.37 +3.18% -7397.00 $12.02B 0.00%
CRSP $56.92 +0.18% -11.97 $5.49B 0.00%
CYTKCytokinetics, Incorporated $71.93 +0.74% -10.98 $8.95B 0.00%
JAZZ $245.57 +0.76% 16.57 $15.43B 0.00%

About AXSM

AXSM is led by CEO Herriot Tabuteau, employs 1,220 people, headquartered in New York City, US, publicly traded since 2015.

AXSM stock trades at $209.92 with a market capitalization of $10.80B. The stock is valued at a price-to-earnings (P/E) ratio of -52.94, price-to-book of 122.73, price-to-sales of 13.16. Over the past 52 weeks the stock has ranged between $112.90 and $260.19, and currently trades 19.3% below its 52-week high.

On profitability, AXSM generates a return on equity (ROE) of -255.60%, return on capital employed of -62.64%, an operating margin of -24.80%, a net profit margin of -24.68%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1160.06 +0.01% JNJ Drug Manufacturers - General $275.21 +1.48% ABBV Drug Manufacturers - General $261.70 +0.66% MRK Drug Manufacturers - General $151.64 +1.19% UNH Medical - Healthcare Plans $399.66 +0.85% NVS Drug Manufacturers - General $162.46 +0.75% AZN Drug Manufacturers - General $161.63 -0.52% AMGN Drug Manufacturers - General $442.84 +1.08% TMO Medical - Diagnostics & Research $608.54 +1.34% NVO Biotechnology $46.77 +3.66% ABT Medical - Devices $110.49 +1.43% GILD Drug Manufacturers - General $149.61 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides